ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2644

Functional Magnetic Resonance Imaging of Working Memory in Fibromyalgia: Support for a “Competing Demands” Theory of Cognitive Function in Chronic Pain

Anson E. Kairys1, Gabriela Ramirez1, Eric Ichesco2, Johnson P. Hampson2, Richard E. Harris2, Daniel J. Clauw3, Tobias Schmidt-Wilcke2 and Jennifer M. Glass4, 1Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 4Psychiatry, University of Michigan, Ann Arbor, MI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cognitive dysfunction, fibromyalgia, memory, neuroimaging and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders II

Session Type: Abstract Submissions (ACR)

Background/Purpose: The primary symptom of fibromyalgia (FM) is chronic widespread pain; however, patients report additional symptoms including decreased concentration and memory. Deficits are seen mainly in tests of working memory (WM) and executive functioning. WM is a cognitive system that involves the ability to store and manipulate mental information for a short period of time, as occurs in the 2-back task. Versions of this task have been used extensively in functional neuroimaging studies of WM. Chronic pain may interfere with cognitive performance, but the neural correlates of this interference remain unclear. We hypothesized that FMs would perform worse on the 2-back task relative to healthy controls (HC), with neural-based changes in blood-oxygen-level-dependent (BOLD) signal.

Methods: 16 FM patients completed a randomized double-blind two-period cross-over study of milnacipran versus placebo. Data reported here are from pre-drug baseline assessment. 13 age and gender matched healthy controls (HC) also participated. Participants performed five blocks of the 2-back task (with 0-back as a control) while in the fMRI scanner.  All fMRI data were pre-processed using SPM5.  Our regressors of interest (2-back and 0-back) were convolved with the hemodynamic response function and applied to voxel-wise statistics. Corresponding contrast images (2back>0back) were then entered into a 2nd level analysis (two-sample t-test) to delineate differences in brain activations between the groups. Regions of interest showing significant changes in BOLD activation during the 2-back task were extracted and analyzed using SPSS 19. 

Results: Behavioral results showed no overall difference between FM and HC groups on the 2-back task; however, there was an interaction with block (F(4, 24)=2.8, p<.05), such that FM patients showed better accuracy during the first block, but did not improve over time.  In contrast, HC subjects improved and by the final block were more accurate than FM patients. While performing the task in the scanner, FM patients displayed significantly less BOLD activity within the left-mid insula (FMConclusion: FM patients displayed reduced activity in the insula, cingulate, and primary somatosensory cortex during a working memory task, when compared to HCs. Behaviorally, FM patients showed no improvement in performance over time, whereas HCs improved.  The results are consistent with a “competing demands” problem with neural resources in FM patients.  It appears as though perception and processing of pain activates areas of the brain that are also involved in cognition, including inhibition and attention networks involved in cognitive executive function, making these networks less available for cognitive tasks.


Disclosure:

A. E. Kairys,
None;

G. Ramirez,
None;

E. Ichesco,
None;

J. P. Hampson,
None;

R. E. Harris,

Pfizer Inc,

2,

Pfizer Inc,

5;

D. J. Clauw,

Pfizer Inc, Forest Laboratories, Merck, Nuvo ,

2,

Pfizer, Forest, Lilly, Merck, Nuvo, J and J ,

5;

T. Schmidt-Wilcke,
None;

J. M. Glass,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-magnetic-resonance-imaging-of-working-memory-in-fibromyalgia-support-for-a-competing-demands-theory-of-cognitive-function-in-chronic-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology